Sunday, October 17, 2021

Covishield

‘I got Covishield from India’: UN General Assembly President

The Covishield vaccine, which has been developed by British-Swedish pharmaceutical company AstraZeneca, is manufactured in India by Pune-based Serum Institute of India.

Vaccine must not be entry barrier for nations: Bharat Biotech

New Delhi: The Co-founder and Joint Managing Director of Hyderabad-based Bharat Biotech, Suchitra Ella has said that vaccines should not be a barrier to...

Allow 2nd Covishield dose after 4 weeks from first dose: Kerala HC to Centre

Kochi: The Kerala High Court has directed the Centre to allow scheduling, on CoWIN portal, of second COVISHIELD dose after four weeks from the...

Editorial: One crore milestone

Sustaining the momentum of the focused push to vaccination needs to remain a high priority

Opinion: Negotiating vaccine inequity and hesitancy

Planning at the district level in India will be crucial in the journey ahead

Editorial: Mixing vaccines

It is argued that such a mixed regimen will help overcome the challenges of the shortfall of certain vaccines and remove hesitancy, especially in settings where multiple Covid-19 vaccines are being used

India’s drug regulator approves study on mixing of Covaxin and Covishield doses

An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on July 29 had recommended granting permission for conducting the study.

Mixing Covishield, Covaxin provides better immunity: ICMR

The results of a study conducted by ICMR showed that the people in the mix and match group had superior immunogenicity profiles against Alpha, Beta and Delta variants of Covid-19

Editorial: Double the vaccination rate

More than half of the adult population has yet to receive even a single dose, despite a slight improvement in coverage in July

Two-dose vaccination highly effective against severe Covid-19 infection

The WHO listed "vaccine hesitancy" as among the top 10 threats to global health.

Vaccines reduce ‘Delta’ severity: Study

The rate of mortality was found to be about 50% lower in fully vaccinated individuals having a breakthrough infection, according to CCMB, AIg study

Only 0.4% mortality among vaccinated: ICMR

The analysis of breakthrough cases is a clear indication that vaccines are the best bet to reduce severity and fatalities among Covid-19 patients.

All you need to know about Kappa variant of Covid-19

Hyderabad: After the Delta and Delta Plus variants of the Covid-19, a new strain – Kappa – has been discovered and three people infected...

Booster shots of Covid vaccine essential, say experts

According to senior doctors in Hyderabad, at some point in the near future, as the protection provided by Covid vaccines wane, there will be demand for booster shots

Covid vaccine availability to improve across country in coming months

Drug regulatory authorities keen on fast-tracking approvals of new Covid vaccine candidates

Latest News

- Advertisement -